Flowserve (NYSE:FLS – Get Rating) and Enovis (NYSE:ENOV – Get Rating) are both mid-cap industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation.
This is a breakdown of recent ratings and recommmendations for Flowserve and Enovis, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Risk and Volatility
Flowserve has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, Enovis has a beta of 2.12, suggesting that its share price is 112% more volatile than the S&P 500.
Valuation and Earnings
This table compares Flowserve and Enovis’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Flowserve||$3.54 billion||1.32||$125.95 million||$0.97||36.81|
|Enovis||$3.85 billion||0.96||$71.66 million||$1.38||50.12|
Flowserve has higher earnings, but lower revenue than Enovis. Flowserve is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks.
This table compares Flowserve and Enovis’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Insider and Institutional Ownership
92.3% of Flowserve shares are owned by institutional investors. Comparatively, 92.0% of Enovis shares are owned by institutional investors. 0.6% of Flowserve shares are owned by company insiders. Comparatively, 8.2% of Enovis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Flowserve beats Enovis on 7 of the 13 factors compared between the two stocks.
Flowserve Company Profile (Get Rating)
Flowserve Corp. engages in the manufacture and provision of aftermarket service for comprehensive flow control systems. It operates through the following segments: Flowserve Pumps Division and Flow Control Division. The Flowserve Pumps Division segment provides pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services. The Flow Control Division segment involves engineered and industrial valves, control valves, actuators and controls and related services. The company was founded in 1790 and is headquartered in Irving, TX.
Enovis Company Profile (Get Rating)
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Receive News & Ratings for Flowserve Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flowserve and related companies with MarketBeat.com's FREE daily email newsletter.